Table 4:

Model for all-cause mortality based on first available visit that included a cardiac MRI

Measure	N	N_e*	Hazard Ratio Confidence interval	P-value
Left ventricular (LV†) ejection fraction per 3% decrease	78	15	1.32 1.12–1.55	<0.001
LV end diastolic volume indexed per 4ml/m2 increase	77	14	1.20 1.09–1.32	<0.001
LV end systolic volume indexed per 2ml/m2 increase	77	14	1.12 1.06–1.19	<0.001
LV cardiac index per 1L/min/m2 increase	76	13	1.53 0.80–2.92	0.200
Circumferential strain (Ecc‡) at base per 1% increase (less negative)	73	12	1.20 0.98–1.46	0.072
Ecc at mid-LV per 0.8% increase (less negative)	73	12	1.23 1.06–1.43	0.007
Global Ecc per 0.6% increase (less negative)	73	12	1.12 1.00–1.25	0.043
Presence of late gadolinium enhancement (LGE§)	76	15	1.19 0.33–4.32	0.800
LGE global severity score per 1 unit increase	73	15	1.34 0.86–2.10	0.190
LGE full width half maximum per 5.9% increase	74	15	1.24 1.06–1.46	0.008
Native T1 mid per 11ms decrease	71	10	1.18 1.04–1.32	0.008
T2 mid per 1ms increase	66	8	1.09 0.84–1.42	0.520
Extracellular volume, mid-LV per 1% increase	65	7	1.04 0.95–1.15	0.400
Brain natriuretic peptide per 1pg/ml increase	60	11	1.00 0.99–1.01	0.500
N-terminal pro b-type natriuretic peptide per 50 pg/ml increase	60	11	1.18 1.00–1.39	0.045
Troponin I per 1pg/ml increase	60	11	1.00 0.99–1.00	0.390

^*N_e – number of events

^†LV – left ventricle

^‡Ecc – circumferential strain

^§LGE – late gadolinium enhancement